{{Rsnum
|rsid=712830
|Gene=EGFR
|Chromosome=7
|position=55019087
|Orientation=plus
|GMAF=0.1111
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=EGFR
}}{{PharmGKB
|RSID=rs712830
|Name_s=EGFR:(-)191C>A
|Gene_s=EGFR
|Feature=5' UTR
|Evidence=PubMed ID:15665278; PubMed ID:17375033; PubMed ID:17455987
|Annotation=Associated with increased expression in vitro.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161145049
}}

{{PMID Auto
|PMID=17875215
|Title=Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy.
|OA=1
}}

{{PMID Auto
|PMID=17956637
|Title=Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study.
|OA=1
}}

{{PMID Auto
|PMID=19102716
|Title=EGFR-targeted therapies in lung cancer: predictors of response and toxicity.
|OA=1
}}

{{on chip | 23andMe v2}}